Article
Androgen receptor variants: RNA-based mechanisms and therapeutic targets
13 May 2020
Abstract excerpt
Prostate cancer is the second leading cause of male cancer death in the United States. The androgen receptor (AR) transcription factor is a master regulator of normal glandular homeostasis in the prostate, as well as growth and survival of prostate cancer cells. Therefore, AR-targeted therapies are effective for improving overall survival of patients with advanced prostate cancer that is incurable by surgery or...
Topics
Join the communities discussing this publication.
